• Sun, May 11, 2025

by: Fortune

Green Dot sale attracts private equity amid sluggish deal climate

by: AOL

Why women's sports is like investing in small-cap stocks

Ariel Investments' and former Washington Commanders president Jason Wright explains his thesis for putting money to work in women's sports.

by: Channel NewsAsia Singapore

Investors welcome news of progress in US-China trade talks

Investors welcomed the conciliatory tone at US-China trade talks over the weekend aimed at cooling a trade war between the world's two largest economies and dispelling some

by: Insider Monkey

Is Realty Income Corporation (O) the Best High-Yield Dividend Stock for 2025 and Beyond?

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Realty Income Corporation (NYSE:O) stands against other best high-yield dividend stocks.

by: USA Today

US stocks end up on hint of trade deal and softer auto sector tariffs. Dow gains 300 pts

U.S. stocks close up after Trump gives the auto sector some tariff relief and Commerce Secretary hints at a done trade deal. Earnings also eyed.

by: moneycontrol.com

Stocks to Watch Today: Yes Bank, Swiggy, Dr Reddys Labs, Navin Fluorine, Bank of India, Manappuram Finance, ABB India, Puravankara in focus on 12 May

Stocks to Watch, 12 May: Stocks like Dr Reddy's Laboratories, Navin Fluorine International, Bank of India, Yes Bank, Swiggy, Manappuram Finance, ABB India, and Puravankara will be in focus on May 12.

by: Seeking Alpha

U.S. Bancorp Preferred Shares Downgrade On Interest Rate Risk (NYSE:USB)

U.S. Bancorp saw loan growth for the second consecutive quarter but faced declining deposits. Find out why USB.PR.A stock is downgraded to Hold.

by: The Motley Fool

3 Brilliant Nuclear Stocks to Buy Now and Hold for the Long Term

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation.

by: The Motley Fool Canada

1 Magnificent Healthcare Stock Down 46% to Buy and Hold Forever

If you're seeking investments you can buy and hold for the long run, this TSX healthcare stock might be an excellent pick to consider for your self-directed portfolio.

by: Insider Monkey

Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond?

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Pfizer Inc.

by: Seeking Alpha

SoFi: Cheaper Than You Would Think (NASDAQ:SOFI)

SoFi Technologies doubles profit estimates in Q1'25 with 200% YoY growth. Learn about its soaring Financial Services and future growth prospects.

by: Seeking Alpha

CVS Health: Firing On All Cylinders, Thanks To The Promising Reversal (NYSE:CVS)

Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.
  • Mon, May 12, 2025

by: reuters.com

Investors welcome news of progress in US-China trade talks; US stock futures rise

Both sides have declined to elaborate on negotiations.

by: The Financial Times

Transcript: Are investors starting to prefer Europe over the US?

Kasia Broussalian talks to Christopher Grimes and Ian Smith

by: The Motley Fool

2 High-Yield Dividend Stocks to Buy in May and Hold Forever

Businesses that are solid enough to perform well over extended periods, while consistently raising their payouts, are precisely what income investors should gravitate toward. Here are two corporations which fit that description: AbbVie ( ABBV -0.71%) and Gilead Sciences ( GILD -1.33%).

by: Seeking Alpha

Continental: Very Localised In The US (OTCMKTS:CTTAY)

Continental boosts profitability with cost savings amid OEM slowdown and macro concerns. Strong tire performance offsets challenges.

by: Seeking Alpha

Tradeweb Markets: Visible Growth Engines And Tailwinds With A Sticky Customer Base (TW)

Discover how Tradeweb Markets (TW) thrives in market volatility with record 1Q25 revenue, growth in rates, credit, and new revenue streams from the ICD...

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Luna Innovations Incorporated in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of AmeraMex International, Inc in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Taoping Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of BrainChip Holdings Ltd in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Kinetic Seas Incorporated in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Mosaic ImmunoEngineering, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Bion Environmental Technologies, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of ROOMLINX INC COM (NV) in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of TCEH Corp in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of SINO-OCEAN ADR in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Telos Corporation in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of HNO International, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Landis+Gyr Group AG in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Twin Vee Powercats Co. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of CytomX Therapeutics, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Propanc Biopharma, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of X3 Holdings Co., Ltd in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of DocGo Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Ainos, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Protalix BioTherapeutics, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Everything Blockchain, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Complete Financial Solutions, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Organogenesis Holdings Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of FAT Brands Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Webuy Global Ltd in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Mitesco, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Shuttle Pharmaceuticals Holdings, Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Better Choice Company Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of Ridder Titan Genesis Corp in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of ENDRA Life Sciences Inc. in recent trading

by: WOPRAI

As of May 12th, 2025, there has been substantial selling of in recent trading

Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond?

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Pfizer Inc.
The article discusses whether Pfizer Inc. (PFE) is the best high-yield dividend stock for 2025 and beyond, highlighting its current financial situation and future prospects. Pfizer offers a high dividend yield of 6.1%, which is attractive to investors seeking income. However, the company faces challenges such as declining revenue from its COVID-19 products and patent expirations for key drugs. Despite these issues, Pfizer is actively working on its pipeline with new drug approvals and acquisitions, such as the acquisition of Seagen, to drive future growth. The article suggests that while Pfizer's high yield is appealing, investors should consider the company's ability to maintain and grow its dividend amidst its current challenges and future opportunities.

Read the Full Insider Monkey Article at:
https://www.msn.com/en-us/money/topstocks/is-pfizer-inc-pfe-the-best-high-yield-dividend-stock-for-2025-and-beyond/ar-AA1EvWPJ

Like: 👍